Ordnance
发表于 2025-3-26 23:38:41
http://reply.papertrans.cn/99/9808/980731/980731_31.png
悠然
发表于 2025-3-27 02:07:36
ASA404 (DMXAA): New Concepts in Tumour Vascular Targeting Therapy
Memorial
发表于 2025-3-27 06:12:06
Vascular Disruptive Agents in Combination with Radiotherapy
asthma
发表于 2025-3-27 12:21:12
Vascular Disruptive Agents for the Treatment of Cancer
共同给与
发表于 2025-3-27 14:43:16
Vascular Disruptive Agents for the Treatment of Cancer978-1-4419-6609-4
割公牛膨胀
发表于 2025-3-27 17:46:11
http://reply.papertrans.cn/99/9808/980731/980731_36.png
傻
发表于 2025-3-28 00:52:53
http://reply.papertrans.cn/99/9808/980731/980731_37.png
最低点
发表于 2025-3-28 03:42:30
http://reply.papertrans.cn/99/9808/980731/980731_38.png
健谈的人
发表于 2025-3-28 08:27:02
Henry C. Mandeville,Peter J. Hoskinntibody molecules with significant affinity for that particular antigen. The former instructional theories of antibody formation clearly were rendered obsolete by this concept. Many scholars attribute the subsequent formal proof of clonal selection to Raff et al. (.).
组装
发表于 2025-3-28 11:55:36
lities used to assess the efficacy of these agents are examiAngiogenesis (formation of new vessels from pre-existing ones) is a crucial early event in the process of tumor development. New vessels supply the tumor with nutrients that are needed for further local growth and enable distant metastases